Successful desensitization using cisplatin after carboplatin-associated hypersensitivity reactions in 3 cases with recurrent ovarian carcinoma
Hosaka, M.; Ebina, Y.; Moriwaki, M.; Hara, Y.; Araki, N.; Todo, Y.; Takeda, M.; Watari, H.; Sakuragi, N.
Gan to Kagaku Ryoho. Cancer and ChemoTherapy 34(9): 1505-1508
2007
ISSN/ISBN: 0385-0684 PMID: 17876157 Document Number: 611808
The standard chemotherapy for ovarian carcinoma is paclitaxel and carboplatin concomitant therapy. This combination is so frequently administered that a carboplatin-associated hypersensitivity reaction may occur after long-term treatment. Recently, we experienced carboplatin-associated hypersensitivity reactions in three cases. They showed symptoms of tachycardia, chest tightness, and dyspnea. We report these cases that could be readministered platinum agent using the cisplatin desensitization method. This method was relatively safe and successful for patients with platinum-sensitive disease.